Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
An AI-based system may reduce the time needed to match patients with cancer to suitable clinical trials.
Nivolumab plus ipilimumab has shown a response benefit when given at an increased dose for those with metastatic urothelial carcinoma.
Higher response rates with T-DXd occurred in patients with gastric cancer and plasma HER2 amplification in circulating tumor DNA in the DESTINY-Gatric01 trial.
The NEOpredict-Lung trial met its primary end point with nivolumab plus relatlimab for patients with resectable non–small cell lung cancer.
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, gives his perspective on the approval of enfortumab vedotin plus pembrolizumab for patients with urothelial carcinoma.
Kidney cancer specialists discuss recent advances in imaging for diagnosis and disease management, highlighting sestamibi and zirconium scans.
Findings from the KEYNOTE-564 study
Talimogene laherparepvec is under clinical development by Amgen and currently in Phase II for Metastatic Renal Cell Carcinoma.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.